
Dameron Levest Jones
Examiner (ID: 6657, Phone: (571)272-0617 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1616, RD00, 1622, 1615, 3991, 1211, 1618, 1621, 1619 |
| Total Applications | 2539 |
| Issued Applications | 1496 |
| Pending Applications | 407 |
| Abandoned Applications | 672 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5858467
[patent_doc_number] => 20020122769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Ascorbic acid analogs for metalloradiopharmaceuticals'
[patent_app_type] => new
[patent_app_number] => 10/081258
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14759
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20020122769.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081258
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081258 | Ascorbic acid analogs for metalloradiopharmaceuticals | Feb 21, 2002 | Issued |
Array
(
[id] => 1040294
[patent_doc_number] => 06869590
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-22
[patent_title] => 'Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque'
[patent_app_type] => utility
[patent_app_number] => 10/080974
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18169
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/869/06869590.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080974
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080974 | Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque | Feb 21, 2002 | Issued |
Array
(
[id] => 6705843
[patent_doc_number] => 20030152577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Dye-bioconjugates for simultaneous optical diagnostic and therapeutic applications'
[patent_app_type] => new
[patent_app_number] => 10/071779
[patent_app_country] => US
[patent_app_date] => 2002-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7980
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20030152577.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071779
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071779 | Dye-bioconjugates for simultaneous optical diagnostic and therapeutic applications | Feb 6, 2002 | Abandoned |
Array
(
[id] => 6308076
[patent_doc_number] => 20020095001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/068447
[patent_app_country] => US
[patent_app_date] => 2002-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10802
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20020095001.pdf
[firstpage_image] =>[orig_patent_app_number] => 10068447
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/068447 | Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors | Feb 5, 2002 | Abandoned |
Array
(
[id] => 718715
[patent_doc_number] => 07048907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products'
[patent_app_type] => utility
[patent_app_number] => 10/060652
[patent_app_country] => US
[patent_app_date] => 2002-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 42781
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/048/07048907.pdf
[firstpage_image] =>[orig_patent_app_number] => 10060652
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/060652 | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products | Jan 29, 2002 | Issued |
Array
(
[id] => 731409
[patent_doc_number] => 07037486
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-02
[patent_title] => 'Labelled phosphoinositides and analogues'
[patent_app_type] => utility
[patent_app_number] => 10/056188
[patent_app_country] => US
[patent_app_date] => 2002-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8321
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/037/07037486.pdf
[firstpage_image] =>[orig_patent_app_number] => 10056188
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/056188 | Labelled phosphoinositides and analogues | Jan 23, 2002 | Issued |
Array
(
[id] => 6374595
[patent_doc_number] => 20020119097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Methods of imaging and targeting vasculature'
[patent_app_type] => new
[patent_app_number] => 10/055842
[patent_app_country] => US
[patent_app_date] => 2002-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5115
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119097.pdf
[firstpage_image] =>[orig_patent_app_number] => 10055842
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/055842 | Methods of imaging and targeting vasculature | Jan 22, 2002 | Issued |
Array
(
[id] => 723246
[patent_doc_number] => 07045115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-16
[patent_title] => 'Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases'
[patent_app_type] => utility
[patent_app_number] => 10/239355
[patent_app_country] => US
[patent_app_date] => 2002-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9555
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/045/07045115.pdf
[firstpage_image] =>[orig_patent_app_number] => 10239355
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/239355 | Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases | Jan 21, 2002 | Issued |
Array
(
[id] => 4704076
[patent_doc_number] => 20080063599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Compounds Which Can Be Used To Diagnose And Monitor Diseases Associated With The Formation Of Amyloid Protein Fibrils'
[patent_app_type] => utility
[patent_app_number] => 10/534749
[patent_app_country] => US
[patent_app_date] => 2002-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9923
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20080063599.pdf
[firstpage_image] =>[orig_patent_app_number] => 10534749
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/534749 | Compounds Which Can Be Used To Diagnose And Monitor Diseases Associated With The Formation Of Amyloid Protein Fibrils | Jan 13, 2002 | Abandoned |
Array
(
[id] => 1289440
[patent_doc_number] => 06630124
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-07
[patent_title] => 'Combination therapy with VIP antagonist'
[patent_app_type] => B1
[patent_app_number] => 09/807557
[patent_app_country] => US
[patent_app_date] => 2002-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13120
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/630/06630124.pdf
[firstpage_image] =>[orig_patent_app_number] => 09807557
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/807557 | Combination therapy with VIP antagonist | Jan 8, 2002 | Issued |
Array
(
[id] => 6749833
[patent_doc_number] => 20030044353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Activatable imaging probes'
[patent_app_type] => new
[patent_app_number] => 10/039831
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19906
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044353.pdf
[firstpage_image] =>[orig_patent_app_number] => 10039831
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/039831 | Activatable imaging probes | Jan 3, 2002 | Abandoned |
Array
(
[id] => 6305303
[patent_doc_number] => 20020094316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Polypodal chelants for metallopharmaceuticals'
[patent_app_type] => new
[patent_app_number] => 10/033769
[patent_app_country] => US
[patent_app_date] => 2001-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19540
[patent_no_of_claims] => 110
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094316.pdf
[firstpage_image] =>[orig_patent_app_number] => 10033769
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/033769 | Polypodal chelants for metallopharmaceuticals | Dec 26, 2001 | Abandoned |
Array
(
[id] => 5985025
[patent_doc_number] => 20020098149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'New macrocyclic chelants useful for metallopharmaceuticals'
[patent_app_type] => new
[patent_app_number] => 10/033765
[patent_app_country] => US
[patent_app_date] => 2001-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13650
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20020098149.pdf
[firstpage_image] =>[orig_patent_app_number] => 10033765
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/033765 | Macrocyclic chelants useful for metallopharmaceuticals | Dec 26, 2001 | Issued |
Array
(
[id] => 1229160
[patent_doc_number] => 06696551
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-24
[patent_title] => '225Ac-HEHA and related compounds, methods of synthesis and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/937030
[patent_app_country] => US
[patent_app_date] => 2001-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12229
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/696/06696551.pdf
[firstpage_image] =>[orig_patent_app_number] => 09937030
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/937030 | 225Ac-HEHA and related compounds, methods of synthesis and methods of use | Dec 19, 2001 | Issued |
Array
(
[id] => 5967414
[patent_doc_number] => 20020090399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Cytoprotective biocompatible containment systems for biologically active materials and methods of making same'
[patent_app_type] => new
[patent_app_number] => 10/029582
[patent_app_country] => US
[patent_app_date] => 2001-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11907
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20020090399.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029582
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029582 | Cytoprotective biocompatible containment systems for biologically active materials and methods of making same | Dec 19, 2001 | Abandoned |
Array
(
[id] => 6729590
[patent_doc_number] => 20030185780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Cosmetic compositions containing at least one heteropolymer and at least one gelling agent and methods of using the same'
[patent_app_type] => new
[patent_app_number] => 10/203254
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15365
[patent_no_of_claims] => 124
[patent_no_of_ind_claims] => 97
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20030185780.pdf
[firstpage_image] =>[orig_patent_app_number] => 10203254
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/203254 | Cosmetic compositions containing at least one heteropolymer and at least one gelling agent and methods of using the same | Dec 11, 2001 | Issued |
Array
(
[id] => 6441474
[patent_doc_number] => 20020176818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'High dose radionuclide complexes for bone marrow suppression'
[patent_app_type] => new
[patent_app_number] => 10/014335
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16543
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20020176818.pdf
[firstpage_image] =>[orig_patent_app_number] => 10014335
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/014335 | High dose radionuclide complexes for bone marrow suppression | Dec 10, 2001 | Issued |
Array
(
[id] => 6744566
[patent_doc_number] => 20030021749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Treatment of cancer and other diseases by administration of positron-emitting radiopharmaceuticals'
[patent_app_type] => new
[patent_app_number] => 10/020368
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3149
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20030021749.pdf
[firstpage_image] =>[orig_patent_app_number] => 10020368
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/020368 | Treatment of cancer and other diseases by administration of positron-emitting radiopharmaceuticals | Dec 10, 2001 | Abandoned |
Array
(
[id] => 5967465
[patent_doc_number] => 20020090406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Tahitian noni juice on COX-1 and COX-2 and tahitian noni juice as a selective COX-2 inhibitor'
[patent_app_type] => new
[patent_app_number] => 10/006014
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3915
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20020090406.pdf
[firstpage_image] =>[orig_patent_app_number] => 10006014
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/006014 | Tahitian noni juice on COX-1 and COX-2 and tahitian noni juice as a selective COX-2 inhibitor | Dec 3, 2001 | Abandoned |
Array
(
[id] => 6360841
[patent_doc_number] => 20020058585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Cationic Group 3 catalyst system'
[patent_app_type] => new
[patent_app_number] => 09/997547
[patent_app_country] => US
[patent_app_date] => 2001-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8983
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058585.pdf
[firstpage_image] =>[orig_patent_app_number] => 09997547
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/997547 | Cationic group 3 catalyst system | Nov 28, 2001 | Issued |